Edwards Lifesciences (EW) insider trading

By person

18 insiders · 55 transactions

7.7×

Mr. Zovighian holds 7.7 times base salary in stock. $9.23M of shares against $1.19M in salary for 2025.

Salary from the company's own proxy. The shares are what Mr. Zovighian last reported holding, valued at $85.65, the price Common Stock was last bought or sold at on the open market here, on 8 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Donald E Bobo Jr

CVP,Strategy/Corp Development

—

$11.15M (12)

−$11.15M

121,409

0.0211%

$10.40M

−36.2%

Bernard J Zovighian

CEO

—

$7.00M (8) scheduled

−$7.00M

107,761

0.0187%

$9.23M

+56.6%

Scott B. Ullem

CVP, Chief Financial Officer

—

$3.87M (7) scheduled

−$3.87M

46,740

0.0081%

$4.00M

+52.9%

Daveen Chopra

CVP, TMTT, Surgical & IHFM

—

$3.19M (4) scheduled

−$3.19M

43,926

0.0076%

$3.76M

+49.7%

Wayne Markowitz

Cvp, Japac

—

$1.04M (5) scheduled

−$1.04M

19,371

0.0034%

$1.66M

+90.2%

Daniel J. Lippis

Cvp, Tavr

—

$924.64K (14) scheduled

−$924.64K

40,034

0.0069%

$3.43M

+69.9%

Annette Bruls

Cvp, Emeacla

—

$237.91K (1)

−$237.91K

17,984

0.0031%

$1.54M

+122.6%

Heisz Leslie Stone

Director

—

$218.12K (1)

−$218.12K

34,199

0.0059%

$2.93M

+13.9%

Andrew M. Dahl

SVP, Corporate Controller

—

$98.39K (2)

−$98.39K

14,615

0.0025%

$1.25M

+171.5%

Larry L Wood

Global President TAVR & Surg

—

206,900

0.0359%

$17.72M

+4.1%

Theodora Mistras

CVP, Chief Financial Officer

—

99,920

0.0173%

$8.56M

—

Nicholas J Valeriani

Director

—

84,423

0.0146%

$7.23M

+14.5%

Paul A Laviolette

Director

—

17,552

0.0030%

$1.50M

+62.9%

Leslie C. Davis

Director

—

9,834

0.0017%

$842.28K

+221.9%

David T Feinberg

Director

—

9,087

0.0016%

$778.30K

+293.7%

Steven R Loranger

Director

—

8,997

0.0016%

$770.59K

—

Ramona Sequeira

Director

—

6,779

0.0012%

$580.62K

—

Kieran Gallahue

Director

—

4,315

0.0007%

$369.58K

—

Edwards Lifesciences

What the insiders did Net selling

By person